Bioventus Inc Cl A (BVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,806 | 9,586 | 11,479 | 13,748 | 24,528 |
| Depreciation Amortization | 12,479 | 34,875 | 23,185 | 14,663 | 7,184 |
| Income taxes - deferred | -17,018 | -9,756 | -1,703 | -981 | 83 |
| Accounts receivable | 4,416 | -20,052 | -13,149 | -9,370 | 2,612 |
| Other Working Capital | -4,708 | -15,145 | -18,129 | -15,551 | -23,669 |
| Other Operating Activity | -1,382 | 23,483 | 8,191 | -3,222 | -28,780 |
| Operating Cash Flow | $-21,019 | $22,991 | $9,874 | $-713 | $-18,042 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,960 | -13,520 | -4,568 | -2,642 | -1,370 |
| Net Acquisitions | -236 | -262,870 | -46,790 | -45,790 | -45,791 |
| Purchase Of Investment | -1,478 | -7,370 | -11,124 | -864 | 513 |
| Investing Cash Flow | $-4,674 | $-283,760 | $-62,482 | $-49,296 | $-46,648 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 15,000 | 277,453 | 0 | 0 | N/A |
| Debt Repayment | -4,509 | -111,250 | -11,250 | -7,500 | -3,750 |
| Common Stock Issued | 2,080 | 109,410 | 108,524 | 108,107 | 110,426 |
| Dividend Paid | N/A | N/A | -183 | 813 | 854 |
| Other Financing Activity | -3,366 | -2,242 | -28 | -11 | -4 |
| Financing Cash Flow | $9,205 | $273,371 | $97,063 | $101,409 | $107,526 |
| Exchange Rate Effect | -71 | -228 | -377 | -171 | -221 |
| Beginning Cash Position | 99,213 | 86,839 | 86,839 | 86,839 | 86,839 |
| End Cash Position | 82,654 | 99,213 | 130,917 | 138,068 | 129,454 |
| Net Cash Flow | $-16,559 | $12,374 | $44,078 | $51,229 | $42,615 |
| Free Cash Flow | |||||
| Operating Cash Flow | -21,019 | 22,991 | 9,874 | -713 | -18,042 |
| Capital Expenditure | -2,960 | -13,520 | -4,568 | -2,642 | -1,370 |
| Free Cash Flow | -23,979 | 9,471 | 5,306 | -3,355 | -19,412 |